Cardiogenic shock is a condition that occurs when an ... This condition is diagnosed by tests such as an EKG, echocardiogram, chest x-ray, cardiac catheterization, and blood tests.

Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

Johnson & Johnson today announced the FDA has expanded its approval of Impella heart pumps to treat specific pediatric ...

Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...

determined that the girl was suffering from refractory septic shock that had led to cardiac and cardiogenic shock, resistant ...

Similarly, the Impella 5.5 with SmartAssist System is approved for short-term use of up to 14 days for paediatric patients weighing at least 30kg, also addressing cardiogenic shock under similar ...

Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in north ...